FDA Drug Approval: Too Fast, Too Slow Or Just About Right?
In the realm of federal oversight over marketplace drug approval, do officials from the U.S. Food and Drug Administration act so cautiously that they dangerously slow up the process and materially delay the marketplace entrance of new drugs and medications that many consumers badly need? Or, conversely, do they signal approval in precipitous fashion, so…